Dmochowski, Roger R.
Newman, Diane K.
Rovner, Eric S.
Zillioux, Jacqueline
Malik, Rena D.
Ackerman, A. Lenore
Funding for this research was provided by:
Urovant Sciences
Article History
Received: 9 March 2023
Accepted: 21 July 2023
First Online: 19 September 2023
Declarations
:
: Roger R. Dmochowski is a consultant for Sumitomo Pharma America. Diane K. Newman is an editor at Digital Science Press; consultant for Cosm Medical, EBT Medical, and Sumitomo Pharma America; and has received funding from the National Institutes of Health and the Society of Urologic Nurses and Associates. Eric S. Rovner has participated in clinical trials on behalf of Sumitomo Pharma America, is a consultant for Hologic, and has received research funding from Allergan/AbbVie and Uromedica. Jacqueline Zillioux has nothing to disclose. Rena D. Malik is an advisor for Sumitomo Pharma America. A. Lenore Ackerman receives research support from MicrogenDx and Medtronic, Inc., and is a consultant for AbbVie and Watershed Medical.
: This article is a review of previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.